Loading…

Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed

Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascu...

Full description

Saved in:
Bibliographic Details
Published in:Balkan medical journal 2021-09, Vol.38 (5), p.304-309
Main Authors: İlhan, Esra, Büyükafşar, Kansu, Tiftik, R Nalan, Seçilmiş, M Ata, Alzayed, Zayed
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 309
container_issue 5
container_start_page 304
container_title Balkan medical journal
container_volume 38
creator İlhan, Esra
Büyükafşar, Kansu
Tiftik, R Nalan
Seçilmiş, M Ata
Alzayed, Zayed
description Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network. To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed. Animal experimentation. Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting. The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein. The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.
doi_str_mv 10.5152/balkanmedj.2021.20014
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_64a06c1dc8064e878d7c8dd7b00b1a09</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A678962211</galeid><doaj_id>oai_doaj_org_article_64a06c1dc8064e878d7c8dd7b00b1a09</doaj_id><sourcerecordid>A678962211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-80475dfcc87922afe4ec6d9221878e413ce3682750b4ba5c395cf08f7523b423</originalsourceid><addsrcrecordid>eNptkt1q3DAQhU1paUKaR2gR9KY33ujf8k0hDWmyZKEhhN6asTTa1da2UstuydtXm01DFyoh6TA68zEaVBTvGV0opvhZC90PGHp02wWnnOWNMvmqOOZM6lIwwV6_aC6OitOUtjQPTYUU9dviSEiljGT6uIiX3qOdEomeTBskd5t4lld5EwZISG5h2vyGRxIHcoujn1PYqRFTmkckYXjKWabYwYSu3FvQkTuYyHUYHFmFviXfIdm5g5F8QfeueOOhS3j6fJ4U918v7y-uy9W3q-XF-aq0suZTaaislPPWmqrmHDxKtNplyUxlUDJhUWjDK0Vb2YKyolbWU-MrxUUruTgplnusi7BtHsbQw_jYRAjNUyCO6wbGKdgOGy2BasucNVRLzHhXWeNc1VLaMqB1Zn3esx7mNrfc4jCN0B1AD2-GsGnW8VdjjKGm3hXz6Rkwxp8zpqnpQ7LYdTBgnFPDVaW1qjjV2fpxb11DLi0MPmai3dmbc12ZWucOsOxa_MeVp8M-2DigDzl-kPDh3ye81P73H4g_7uy2mw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576657206</pqid></control><display><type>article</type><title>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</title><source>PubMed Central</source><creator>İlhan, Esra ; Büyükafşar, Kansu ; Tiftik, R Nalan ; Seçilmiş, M Ata ; Alzayed, Zayed</creator><creatorcontrib>İlhan, Esra ; Büyükafşar, Kansu ; Tiftik, R Nalan ; Seçilmiş, M Ata ; Alzayed, Zayed</creatorcontrib><description>Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network. To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed. Animal experimentation. Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting. The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein. The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.</description><identifier>ISSN: 2146-3123</identifier><identifier>EISSN: 2146-3131</identifier><identifier>DOI: 10.5152/balkanmedj.2021.20014</identifier><identifier>PMID: 34558416</identifier><language>eng</language><publisher>Turkey: Galenos Yayinevi Tic. Ltd</publisher><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs &amp; derivatives ; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology ; Amides - pharmacology ; Animals ; Atorvastatin - pharmacology ; Extremities, Lower ; Health aspects ; Hemodynamics ; Isolation perfusion (Physiology) ; Leg ; Muscle Relaxants, Central - pharmacology ; Muscles ; Original ; Perfusion - methods ; Physiological aspects ; Protein kinases ; Pyridines - pharmacology ; Rats ; rho-Associated Kinases - metabolism ; rhoA GTP-Binding Protein - metabolism ; Vasodilation - drug effects ; Vasodilation - physiology ; Vasodilator Agents - pharmacology</subject><ispartof>Balkan medical journal, 2021-09, Vol.38 (5), p.304-309</ispartof><rights>COPYRIGHT 2021 Galenos Yayinevi Tic. Ltd.</rights><rights>Copyright 2021 authors 2021 authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880892/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880892/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34558416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>İlhan, Esra</creatorcontrib><creatorcontrib>Büyükafşar, Kansu</creatorcontrib><creatorcontrib>Tiftik, R Nalan</creatorcontrib><creatorcontrib>Seçilmiş, M Ata</creatorcontrib><creatorcontrib>Alzayed, Zayed</creatorcontrib><title>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</title><title>Balkan medical journal</title><addtitle>Balkan Med J</addtitle><description>Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network. To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed. Animal experimentation. Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting. The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein. The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.</description><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs &amp; derivatives</subject><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>Atorvastatin - pharmacology</subject><subject>Extremities, Lower</subject><subject>Health aspects</subject><subject>Hemodynamics</subject><subject>Isolation perfusion (Physiology)</subject><subject>Leg</subject><subject>Muscle Relaxants, Central - pharmacology</subject><subject>Muscles</subject><subject>Original</subject><subject>Perfusion - methods</subject><subject>Physiological aspects</subject><subject>Protein kinases</subject><subject>Pyridines - pharmacology</subject><subject>Rats</subject><subject>rho-Associated Kinases - metabolism</subject><subject>rhoA GTP-Binding Protein - metabolism</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilation - physiology</subject><subject>Vasodilator Agents - pharmacology</subject><issn>2146-3123</issn><issn>2146-3131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkt1q3DAQhU1paUKaR2gR9KY33ujf8k0hDWmyZKEhhN6asTTa1da2UstuydtXm01DFyoh6TA68zEaVBTvGV0opvhZC90PGHp02wWnnOWNMvmqOOZM6lIwwV6_aC6OitOUtjQPTYUU9dviSEiljGT6uIiX3qOdEomeTBskd5t4lld5EwZISG5h2vyGRxIHcoujn1PYqRFTmkckYXjKWabYwYSu3FvQkTuYyHUYHFmFviXfIdm5g5F8QfeueOOhS3j6fJ4U918v7y-uy9W3q-XF-aq0suZTaaislPPWmqrmHDxKtNplyUxlUDJhUWjDK0Vb2YKyolbWU-MrxUUruTgplnusi7BtHsbQw_jYRAjNUyCO6wbGKdgOGy2BasucNVRLzHhXWeNc1VLaMqB1Zn3esx7mNrfc4jCN0B1AD2-GsGnW8VdjjKGm3hXz6Rkwxp8zpqnpQ7LYdTBgnFPDVaW1qjjV2fpxb11DLi0MPmai3dmbc12ZWucOsOxa_MeVp8M-2DigDzl-kPDh3ye81P73H4g_7uy2mw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>İlhan, Esra</creator><creator>Büyükafşar, Kansu</creator><creator>Tiftik, R Nalan</creator><creator>Seçilmiş, M Ata</creator><creator>Alzayed, Zayed</creator><general>Galenos Yayinevi Tic. Ltd</general><general>Trakya University School of Medicine</general><general>Galenos Publishing House</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210901</creationdate><title>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</title><author>İlhan, Esra ; Büyükafşar, Kansu ; Tiftik, R Nalan ; Seçilmiş, M Ata ; Alzayed, Zayed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-80475dfcc87922afe4ec6d9221878e413ce3682750b4ba5c395cf08f7523b423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs &amp; derivatives</topic><topic>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>Atorvastatin - pharmacology</topic><topic>Extremities, Lower</topic><topic>Health aspects</topic><topic>Hemodynamics</topic><topic>Isolation perfusion (Physiology)</topic><topic>Leg</topic><topic>Muscle Relaxants, Central - pharmacology</topic><topic>Muscles</topic><topic>Original</topic><topic>Perfusion - methods</topic><topic>Physiological aspects</topic><topic>Protein kinases</topic><topic>Pyridines - pharmacology</topic><topic>Rats</topic><topic>rho-Associated Kinases - metabolism</topic><topic>rhoA GTP-Binding Protein - metabolism</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilation - physiology</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>İlhan, Esra</creatorcontrib><creatorcontrib>Büyükafşar, Kansu</creatorcontrib><creatorcontrib>Tiftik, R Nalan</creatorcontrib><creatorcontrib>Seçilmiş, M Ata</creatorcontrib><creatorcontrib>Alzayed, Zayed</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Balkan medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>İlhan, Esra</au><au>Büyükafşar, Kansu</au><au>Tiftik, R Nalan</au><au>Seçilmiş, M Ata</au><au>Alzayed, Zayed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed</atitle><jtitle>Balkan medical journal</jtitle><addtitle>Balkan Med J</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>38</volume><issue>5</issue><spage>304</spage><epage>309</epage><pages>304-309</pages><issn>2146-3123</issn><eissn>2146-3131</eissn><abstract>Rho/ROCK signaling has been demonstrated to be involved in the vascular reactivity of many arterial networks. However, RhoA expression and the contribution of Rho/ROCK pathway to the control of perfusion pressure have not been investigated in the rat hind limb vascular bed as a skeletal muscle vascular network. To investigate the contribution of the Rho/ROCK pathway in the control of perfusion pressure in the isolated-perfused rat hind limb vascular bed. Animal experimentation. Two Rho inhibitors (atorvastatin and C3 exoenzyme) and ROCK inhibitors (Y-27632 and fasudil) were tested on the phenylephrine-elevated perfusion pressure in the isolated-perfused rat hind limb vascular bed. Furthermore, we sought the expression of RhoA protein in the femoral, popliteal and saphenous arteries as well as quadriceps and gastrocnemius muscles by Western blotting. The ROCK inhibitors Y-27632 and fasudil (both 10-8 to 10-5 M) induced substantial vasodilatations. The maximum vasodilatations induced by Y-27632 and fasudil (both at 10-5 M) were 84.0 ± 6.9% and 76.9 ± 6.9%, respectively (P = .091). Y-27632 was not more potent than fasudil, as the EC50 values for Y-27632 and fasudil were 0.7 ± 2.1 μM and 2.5 ± 2.4 μM, respectively (P = .177). Atorvastatin (10-7 to 10-4 M) and C3 exoenzyme (3 × 10-8 M) also produced vasodilatation (maximum vasodilatation; 20.3 ± 1.7% and 13.7 ± 3.6%, respectively). The EC50 value for atorvastatin was 94.9 ± 1.2 μM. The western blot analysis showed that the femoral, saphenous, and popliteal arteries, as well as the gastrocnemius and quadriceps muscles, express RhoA protein. The Rho/ROCK pathway contributes significantly to the control of perfusion pressure in the rat hind limb vascular bed.</abstract><cop>Turkey</cop><pub>Galenos Yayinevi Tic. Ltd</pub><pmid>34558416</pmid><doi>10.5152/balkanmedj.2021.20014</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2146-3123
ispartof Balkan medical journal, 2021-09, Vol.38 (5), p.304-309
issn 2146-3123
2146-3131
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_64a06c1dc8064e878d7c8dd7b00b1a09
source PubMed Central
subjects 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology
Amides - pharmacology
Animals
Atorvastatin - pharmacology
Extremities, Lower
Health aspects
Hemodynamics
Isolation perfusion (Physiology)
Leg
Muscle Relaxants, Central - pharmacology
Muscles
Original
Perfusion - methods
Physiological aspects
Protein kinases
Pyridines - pharmacology
Rats
rho-Associated Kinases - metabolism
rhoA GTP-Binding Protein - metabolism
Vasodilation - drug effects
Vasodilation - physiology
Vasodilator Agents - pharmacology
title Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20the%20Rho/Rho-Kinase%20Pathway%20on%20Perfusion%20Pressure%20in%20the%20Isolated-Perfused%20Rat%20Hind%20Limb%20Vascular%20Bed&rft.jtitle=Balkan%20medical%20journal&rft.au=%C4%B0lhan,%20Esra&rft.date=2021-09-01&rft.volume=38&rft.issue=5&rft.spage=304&rft.epage=309&rft.pages=304-309&rft.issn=2146-3123&rft.eissn=2146-3131&rft_id=info:doi/10.5152/balkanmedj.2021.20014&rft_dat=%3Cgale_doaj_%3EA678962211%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-80475dfcc87922afe4ec6d9221878e413ce3682750b4ba5c395cf08f7523b423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2576657206&rft_id=info:pmid/34558416&rft_galeid=A678962211&rfr_iscdi=true